RPRX
Royalty Pharma plc
Halal Rating :
Last Price
$24.94
Last updated:
Market Cap
$15.71b
7D Change
0.38%
1 Year Change
-8.93%
Company Overview
Industries
Exchange
Nasdaq
Next Earnings Date
Royalty Pharma plc was founded in 1996 and is based in New York, New York. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $564.69m | $-103878000.0 | - | $66.51m | 0.00% | 64.02% |
| June 30, 2024 | $537.27m | $316.65m | - | $49.01m | 0.00% | 15.48% |
| March 31, 2024 | $567.98m | $685.98m | - | $44.23m | 0.00% | 6.45% |
Company Impact
Help us evaluate Royalty Pharma plc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.